Commercialisation

Strengthening defence with hidden power

A new generation of camouflaged photovoltaic modules is under development through a collaboration between Praxis Labs (Praxis) and researchers from the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS) – with critical fabrication and technical support provided by the Australian National Fabrication Facility (ANFF). The project, supported by the Defence Trailblazer, aims to […]

Strengthening defence with hidden power Read More »

Clear vision for the globe

OOXii has developed a Vision Kit containing everything a basic health worker needs to test vision and assemble affordable, customised glasses on the spot in remote and low-resource communities. One billion people worldwide experience impaired vision simply because they lack access to affordable glasses. Described by the World Health Organization as a global health crisis,

Clear vision for the globe Read More »

Simply breathtaking

Introducing the Ketowhistle: a non-invasive, breath-based sensor for easy, real-time ketone monitoring, revolutionising diabetes management. A sharp jab to your fingertip brings a moment of pain. A drop of blood emerges, which can be a bit unsettling. You put the drop of blood on a strip and wait for the results. Finger prick tests are

Simply breathtaking Read More »

Sounding better already

Misti’s acoustic nebuliser mask offers child-friendly, efficient respiratory relief, reducing hospital visits and waiting times. When a child’s sniffles turn into coughing, then hacking, their condition worsens. It could be minor, or something more. As their discomfort grows, so does their parents’ stress, leading to a visit to the GP for relief and peace of

Sounding better already Read More »

Breakthroughs with every beat

Breakthroughs with every beat Biotech startup Dynomics creates scalable, authentic cardiac organoids to unlock the root causes of heart failure. Cardiovascular disease remains the leading cause of death worldwide. In Australia alone, each day 157 individuals experience an acute coronary event, and 112 suffer a stroke. Current heart failure treatments focus on the aftermath, involving

Breakthroughs with every beat Read More »

Seeing our cities in a new light

Seeing our cities in a new light Interromate’s robust optical fibre sensors provide the right ‘eyes’ to monitor the health of urban infrastructure threatened by harsh environments. Urban life in Australia is a focus of public discussion, especially around sustainability and population distribution. With 67% of Australians living in capital cities, these areas often feel

Seeing our cities in a new light Read More »

Co-designing the Future of MedTech

Co-designing the future of MedTech ANFF’s Designer in Residence program fosters human-centred design, empowering startups to create user-driven, impactful technological solutions. Innovation alone does not guarantee a product’s success. Even groundbreaking technologies can fail if they overlook everyday consumer needs. High-profile failures like Google Health Records, Segway PT and Evian’s Water Bra illustrate how neglecting

Co-designing the Future of MedTech Read More »

Melbourne Medtech startup Haemograph awarded ANFF-C funding

Melbourne healthcare startup Haemograph awarded ANFF-C Gate 2 funding ANFF-C is excited to announce that Haemograph has been awarded Gate 2 pre-seed funding to aid in the commercialisation of its novel blood rheometer. Haemograph is a Melbourne-based start-up revolutionising healthcare with their innovative portable, point-of-care, blood coagulation rheometer. The cutting-edge device measures the viscoelastic properties

Melbourne Medtech startup Haemograph awarded ANFF-C funding Read More »

2024 Showcase highlights ANFF connections with industry and commercialisation

2024 Showcase highlights ANFF connections with industry and commercialisation ANFF facilities provide the critical infrastructure and expertise required to accelerate and de-risk technology development. The availability of these experts and capabilities, including tools for initial prototyping and complete, industry-relevant process trains, adds immense value to early innovations. ANFF and ANFF-C enable researchers to develop new

2024 Showcase highlights ANFF connections with industry and commercialisation Read More »

ANFF-C supports VividWhite in bringing a novel glaucoma treatment device to market

ANFF-C supports VividWhite in bringing a novel glaucoma treatment device to market ANFF-C is excited to announce that VividWhite has been awarded Gate 2 pre-seed funding to aid in the commercialisation of VividFlo, a revolutionary microfluidic medical device that provides a novel approach to glaucoma treatment. Glaucoma is the leading cause of irreversible blindness worldwide,

ANFF-C supports VividWhite in bringing a novel glaucoma treatment device to market Read More »